RK
Ray Kurzweil (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in United Therapeutics Corporation (UTHR). The largest single filing was $2.4M of UTHR (4,910 sh × $489.02, as filed), executed Mar 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.4M
shares × price, as filed
Last traded
Mar 4
Filed Mar 5
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$2.4M4,910 sh × $489.02
Exec Mar 4
Filed Mar 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.7M
14,900 sh across 8 lots
Exec Feb 28 2025
Filed Mar 3 2025 · 5:30 PM ET